StockData
Kalaris Therapeutics, Inc. logo

Kalaris Therapeutics, Inc. (KLRS) shareholders

KLRSNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30
$1.43−0.03 (-2.05%)

Close on Nov 17, 2026Market cap $34.04MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
75.8%
18M of 24M shares
Institutional holders
57
10 new, 11 sold out
Net institutional buying
-1M
In Q2 2026
Insider trades, 12 months
2 buys · 1 sales
Net bought $6.17M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Srinivas Akkaraju
Joint filing with Samsara BioCapital GP, LLC (44.90%), Samsara BioCapital, L.P. (44.80%) and 2 more
12,900,58354.20%13D (active) amendmentMay 20, 2026
Samsara BioCapital GP, LLC
Joint filing with Samsara BioCapital, L.P. (61.20%), Srinivas Akkaraju (61.20%)
11,448,08161.20%13D (active)Mar 18, 2025
Ting Jia
Joint filing with Octagon Capital Advisors LP (9.70%), Octagon Investments Master Fund LP (9.70%)
11,202,0009.70%13G (passive)Sep 30, 2024
Invus Public Equities, L.P.
Joint filing with Invus Public Equities Advisors, LLC (5.80%), Artal International S.C.A (5.80%) and 5 more
6,597,1675.80%13G (passive) amendmentDec 31, 2023
Matthew D. Perry
Joint filing with Coastlands Capital LP (5.69%), Coastlands Capital Partners LP (5.69%) and 2 more
1,355,1195.69%13G (passive)Oct 19, 2026
Roderick Wong
Joint filing with RTW Investments, LP (5.70%)
1,300,0005.70%13G (passive)Dec 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of KLRSValueChange% of portfolio
Samsara BioCapital, LLC12,881,17554.11%$52.43M−66,9064.31%
Rtw Investments, LP1,300,0005.46%$5.29M–0.05%
Alyeska Investment Group, L.P.572,6872.41%$2.33M–0.01%
Siren, L.L.C.435,7981.83%$1.77M–0.04%
Vanguard Capital Management LLC398,7121.67%$1.62M+143,3640.00%
Ikarian Capital, LLC360,0001.51%$1.47M–0.16%
UBS Group AG262,1311.10%$1.07M+255,9470.00%
Renaissance Technologies LLC149,3510.63%$607.86K+83,2000.00%
Marshall Wace, Llp139,2010.58%$566.55K+71,3220.00%
Geode Capital Management, LLC114,0370.48%$464.29K+26,4920.00%
Woodline Partners LP100,0000.42%$407.00K–0.00%
ADAR1 Capital Management, LLC100,0000.42%$407.00K–0.02%
WHI TRUST Co LLC97,4930.41%$396.80K–0.26%
Raymond James Financial Inc97,1640.41%$395.46K−21,7230.00%
Citadel Advisors LLC95,7720.40%$389.79KNew0.00%
Boothbay Fund Management, LLC92,2610.39%$375.50K–0.00%
Verdad Advisers, LP80,2970.34%$326.81KNew0.31%
Morgan Stanley72,3260.30%$294.37K+33,9820.00%
Vanguard Fiduciary Trust Co66,1790.28%$269.35K+29,4620.00%
BlackRock, Inc.54,4420.23%$221.58K+18,3990.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20265718M75.8%10 / 189 / 111M2M
Q1 20265819M78.6%15 / 177 / 71M0M
Q4 20255118M75.7%24 / 118 / 55M1M
Q3 20253213M55.5%8 / 106 / 61M1M
Q2 20253013M56.1%4 / 97 / 60M1M
Q1 20253214M58.3%32 / 00 / 014M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

15 funds held KLRS in Q2 2026, 77% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of KLRSValue% of fundAs of
Vanguard Total Stock Market Index Fund255,3371.07%$1.04M0.00%Jun 30, 2026
Vanguard Extended Market Index Fund137,3730.58%$559.11K0.00%Jun 30, 2026
Fidelity Extended Market Index Fund34,5740.15%$182.20K0.00%May 31, 2026
Ultra-Small Company Market Fund32,5000.14%$132.28K0.09%Jun 30, 2026
iShares Micro-Cap ETF25,9240.11%$105.51K0.01%Jun 30, 2026
Fidelity Nasdaq Composite Index Fund16,8290.07%$88.69K0.00%May 31, 2026
Fidelity Total Market Index Fund9,8850.04%$52.09K0.00%May 31, 2026
Fidelity Series Total Market Index Fund9,5750.04%$50.46K0.00%May 31, 2026
Goldman Sachs Absolute Return Tracker Fund8,0200.03%$32.64K0.00%Jun 30, 2026
VIP Disciplined Small Cap Portfolio7,8060.03%$31.77K0.00%Jun 30, 2026
Vanguard Balanced Index Fund6,0020.03%$24.43K0.00%Jun 30, 2026
Dimensional US Core Equity 1 ETF3,2960.01%$11.57K0.00%Jul 31, 2026
U.S. Vector Equity Portfolio2,7500.01%$9.65K0.00%Jul 31, 2026
Dimensional U.S. Core Equity 2 ETF2,6140.01%$9.18K0.00%Jul 31, 2026
1290 VT Micro Cap Portfolio1,7250.01%$7.02K0.00%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Andrew OxtobySee Remarks, Director––Mar 20, 2026
Vikas SinhaSee Remarks, Director, 10% owner774,1183.25%Feb 24, 2025
Diana BrainardChief Executive Officer, Director723,3633.04%Nov 20, 2024
Amy O'Leary VandekopVP, Corporate Controller9480.00%Aug 28, 2026
Liisa Ann BaykoChief Financial Officer––Jul 20, 2026
Brett R. HagenChief Accounting Officer0–Mar 23, 2026
Matthew GallChief Financial Officer––Mar 20, 2026
Matthew FeinsodChief Medical Officer4,0300.02%Mar 20, 2026
Edward MillerGeneral Counsel21,5750.09%Feb 24, 2025
Laurie KeatingDirector––Aug 3, 2026
Leone D. PattersonDirector––Jun 4, 2026
Morana Jovan-EmbiricosDirector26,603,054111.75%Jun 4, 2026
Napoleone FerraraDirector504,0002.12%Jun 4, 2026
Anthony P. AdamisDirector––Jun 4, 2026
Srinivas AkkarajuDirector12,948,08154.39%Jun 4, 2026
David HallalDirector19,677,54682.66%Jun 4, 2026
Michael DybbsDirector––Jun 4, 2026
Samir Chandrakant PatelDirector352,8001.48%Apr 11, 2025
Samsara Opportunity Fund, L.P.10% owner12,948,08154.39%May 22, 2026
Samsara BioCapital, L.P.10% owner12,915,52054.26%May 22, 2026
Samsara Opportunity Fund GP, LLC10% owner––May 22, 2026
Samsara BioCapital GP, LLC10% owner11,448,08148.09%May 22, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Samsara BioCapital, L.P.
10% owner
May 20, 2026Other+14,937––14,937
Samsara BioCapital, L.P.
10% owner
May 20, 2026Buy+244,300$4.83$1.18M2,224,147
Samsara BioCapital, L.P.
10% owner
May 20, 2026Other−66,906––10,657,028
Samsara BioCapital, L.P.
10% owner
May 20, 2026Other+4,471––19,408
Brett R. Hagen
Chief Accounting Officer
Mar 20, 2026Sale−1,915$6.72$12.87K0
Srinivas Akkaraju
Director, 10% owner
Dec 22, 2025Award+1,500,000$10.00$15.00M1,500,000
Samsara Opportunity Fund, L.P.
10% owner
Dec 18, 2025Buy+479,847$10.42$5.00M1,979,847
Brett R. Hagen
Chief Accounting Officer
Mar 26, 2025Sale−907$8.97$8.14K1,925
Napoleone Ferrara
Director
Mar 18, 2025Award+504,000––504,000
Samir Chandrakant Patel
Director
Mar 18, 2025Award+252,000––252,000
Samir Chandrakant Patel
Director
Mar 18, 2025Award+100,800––100,800
Matthew Feinsod
Chief Medical Officer
Mar 18, 2025Award+4,030––4,030
Srinivas Akkaraju
Director, 10% owner
Mar 18, 2025Award+11,444,503––11,444,503
Brett R. Hagen
Chief Accounting Officer
Feb 21, 2025Sale−96$10.08$9682,832
Vikas Sinha
See Remarks, Director, 10% owner
Feb 21, 2025Sale−303$10.08$3.05K49,129
Edward Miller
General Counsel
Feb 21, 2025Sale−106$10.08$1.07K6,517
Vikas Sinha
See Remarks, Director, 10% owner
Jan 23, 2025Sale−116$9.45$1.10K49,445
Vikas Sinha
See Remarks, Director, 10% owner
Jan 23, 2025Sale−13$9.94$12949,432
Brett R. Hagen
Chief Accounting Officer
Jan 23, 2025Sale−32$9.45$3022,932
Brett R. Hagen
Chief Accounting Officer
Jan 23, 2025Sale−4$9.94$402,928
Edward Miller
General Counsel
Jan 23, 2025Sale−5$9.94$506,623
Edward Miller
General Counsel
Jan 23, 2025Sale−47$9.45$4446,628
Vikas Sinha
See Remarks, Director, 10% owner
Jan 10, 2025Sale−979$0.44$4311,139,915
Edward Miller
General Counsel
Jan 10, 2025Sale−409$0.44$180153,541
Brett R. Hagen
Chief Accounting Officer
Jan 10, 2025Sale−332$0.44$14668,174
Edward Miller
General Counsel
Dec 11, 2024Gift−57,549––153,950
Edward Miller
General Counsel
Dec 11, 2024Gift+57,549––346,348
Diana Brainard
Chief Executive Officer, Director
Nov 19, 2024Sale−8,706$0.55$4.79K723,363
Brett R. Hagen
Chief Accounting Officer
Nov 19, 2024Sale−554$0.55$30568,506
Vikas Sinha
See Remarks, Director, 10% owner
Nov 19, 2024Sale−3,186$0.55$1.75K1,140,894
Edward Miller
General Counsel
Nov 19, 2024Sale−432$0.55$238211,499
Vikas Sinha
See Remarks, Director, 10% owner
Nov 5, 2024Sale−5,136$0.86$4.42K1,144,080
Brett R. Hagen
Chief Accounting Officer
Nov 5, 2024Sale−1,655$0.86$1.42K69,060
Edward Miller
General Counsel
Nov 5, 2024Sale−2,272$0.86$1.95K211,931
Diana Brainard
Chief Executive Officer, Director
Nov 5, 2024Sale−10,609$0.86$9.12K732,069
Vikas Sinha
See Remarks, Director, 10% owner
Oct 22, 2024Sale−1,882$0.77$1.45K1,149,216
Edward Miller
General Counsel
Oct 22, 2024Sale−766$0.77$590214,203
Brett R. Hagen
Chief Accounting Officer
Oct 22, 2024Sale−486$0.77$37470,715
Diana Brainard
Chief Executive Officer, Director
Oct 21, 2024Sale−9,752$0.78$7.61K742,678
Vikas Sinha
See Remarks, Director, 10% owner
Oct 21, 2024Sale−1,546$0.78$1.21K1,151,098
Edward Miller
General Counsel
Oct 21, 2024Sale−635$0.78$495214,969
Brett R. Hagen
Chief Accounting Officer
Oct 21, 2024Sale−479$0.78$37471,201
Diana Brainard
Chief Executive Officer, Director
Oct 3, 2024Sale−1,493$0.81$1.21K752,430
Brett R. Hagen
Chief Accounting Officer
Oct 3, 2024Sale−301$0.81$24471,680
Edward Miller
General Counsel
Oct 3, 2024Sale−377$0.81$305215,604
Vikas Sinha
See Remarks, Director, 10% owner
Oct 3, 2024Sale−940$0.81$7611,152,644
Diana Brainard
Chief Executive Officer, Director
Aug 20, 2024Sale−5,390$0.74$3.99K753,923
Brett R. Hagen
Chief Accounting Officer
Aug 19, 2024Sale−544$0.76$41371,981
Edward Miller
General Counsel
Aug 19, 2024Sale−422$0.76$321215,981
Vikas Sinha
See Remarks, Director, 10% owner
Aug 19, 2024Sale−3,159$0.76$2.40K1,153,584
Diana Brainard
Chief Executive Officer, Director
Aug 19, 2024Sale−3,091$0.76$2.35K759,313
Brett R. Hagen
Chief Accounting Officer
Aug 5, 2024Sale−1,692$0.73$1.24K72,525
Vikas Sinha
See Remarks, Director, 10% owner
Aug 5, 2024Sale−5,251$0.73$3.83K1,156,743
Edward Miller
General Counsel
Aug 5, 2024Sale−2,323$0.73$1.70K216,403
Diana Brainard
Chief Executive Officer, Director
Aug 5, 2024Sale−10,847$0.73$7.92K762,404
Edward Miller
General Counsel
Jul 22, 2024Sale−757$0.74$560218,726
Vikas Sinha
See Remarks, Director, 10% owner
Jul 22, 2024Sale−1,858$0.74$1.37K1,161,994
Brett R. Hagen
Chief Accounting Officer
Jul 22, 2024Sale−481$0.74$35674,217
Edward Miller
General Counsel
Jul 19, 2024Sale−634$0.75$476219,483
Diana Brainard
Chief Executive Officer, Director
Jul 19, 2024Sale−9,731$0.75$7.30K773,251

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
1.54%
0M shares short
Days to cover
5.4
At 0M shares a day
Change since last report
+19.7%
From 0M shares
Short volume, 20 days
44.6%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Kalaris Therapeutics's stock actually held short. Settlement fails (shares not delivered on time) peaked at 17,820 shares on Sep 21, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Brett R. Hagen
Officer
Mar 20, 20261,915$12.87KMar 20, 2026Restricted stock vesting under a registered plan
Edward Miller
Officer
Feb 24, 2025289$1.07KFeb 21, 2025Restricted Stock
Vikas Sinha
Owner, Officer, Director
Feb 24, 2025709$3.05KFeb 21, 2025Restricted Stock
Brett R. Hagen
Officer
Feb 24, 202596$967Feb 21, 2025Restricted Stock
Edward Miller
Officer
Jan 24, 202552$495Jan 23, 2025Restricted Stock
Brett R. Hagen
Officer
Jan 24, 202536$341Jan 23, 2025Restricted Stock
Vikas Sinha
Owner, Officer, Director
Jan 24, 2025129$1.23KJan 23, 2025Restricted Stock
Brett R. Hagen
Officer
Jan 10, 2025332$146Jan 10, 2025Restricted Stock
Edward Miller
Officer
Jan 10, 2025409$180Jan 10, 2025Restricted Stock
Vikas Sinha
Owner, Officer, Director
Jan 10, 2025979$431Jan 10, 2025Restricted Stock
Brett R. Hagen
Officer
Nov 19, 2024554$302Nov 19, 2024Restricted Stock
Edward Miller
Officer
Nov 19, 2024432$235Nov 19, 2024Restricted Stock
Diana Brainard
Officer, Director
Nov 19, 20248,706$4.76KNov 19, 2024Restricted Stock
Vikas Sinha
Owner, Officer, Director
Nov 19, 20243,186$1.74KNov 19, 2024Restricted Stock
Edward Miller
Officer
Nov 5, 20242,272$1.97KNov 5, 2024Restricted Stock

See a number that looks wrong?